Ministers have today signed a multi-million pound deal with pharmaceutical giants GlaxoSmithKline and Sanofi Pasteur for 60million doses of another potential Covid-19 vaccine. Number 10 has now secured four different types of experimental coronavirus jabs, giving the UK access to a total of 250million doses — enough to allow everyone in Britain to have four each, if they work. Scientists have yet to trial GSK/Sanofi’s vaccine on humans and studies to prove it works won’t begin until September. Other contenders purchased by Number 10 have already shown signs of promise in tests. The Department for Business, Energy and Industrial Strategy said the jab — bought in a deal rumoured to cost £500million — could be given to high-risk Britons as early as the first half of next year, if it passes trials. Britain last month began shoring up stocks of experimental jabs all over the world in its spread-betting approach in the hope that at least one of them will pay off. Health chiefs hope the Oxford University vaccine it has agreed to buy — considered one of the front-runners in the global race to end the pandemic — could even be ready before the end of the year. The deal… Read full this story
- Sanofi to buy Synthorx for $2.5 billion to expand in cancer
- Silicon Valley’s psychedelic wonder drug is almost here
- Good Old Grateful Dead
- What is 5G? The business guide to next-generation wireless technology
UK Government signs '£500million' deal with drug giants GlaxoSmithKline and Sanofi for 60million doses of fourth potential coronavirus vaccine - even though it hasn't been tested on humans yet have 231 words, post on www.dailymail.co.uk at July 29, 2020. This is cached page on GameMaz. If you want remove this page, please contact us.